Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GSK2578215A

GSK2578215A
GSK2578215A is a potent and selective LRRK2 kinase inhibitor.
Catalog No. T2240Cas No. 1285515-21-0
Select Batch
Purity:99.94%
Contact us for more batch information
Resource Download

GSK2578215A

Catalog No. T2240Cas No. 1285515-21-0
GSK2578215A is a potent and selective LRRK2 kinase inhibitor.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
5 mg$29In Stock
10 mg$43In Stock
25 mg$84In Stock
50 mg$161In Stock
100 mg$238In Stock
200 mg$358In Stock
1 mL x 10 mM (in DMSO)$29In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "GSK2578215A"

Product Introduction

Bioactivity
Description
GSK2578215A is a potent and selective LRRK2 kinase inhibitor.
Targets&IC50
LRRK2 (WT):10.9 nM, LRRK2 (G2019S):8.9 nM
In vitro
Administering 100 mg/kg intraperitoneally (i.p.) of GSK2578215A inhibits the phosphorylation of Ser910 and Ser935 in the spleen and kidneys of mice, but has no effect in the brain.
In vivo
In SH-SY5Y cells, GSK2578215A impairs autophagic flux by altering autophagosome-lysosome fusion and induces mitochondrial autophagy through Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling. Furthermore, GSK2578215A induces dose-dependent inhibition of Ser910 and Ser935 phosphorylation in HEK293 cells stably transfected with wild-type LRRK2 and LRRK2 [G2019S], and similarly promotes dose-dependent dephosphorylation of Ser910 and Ser935 in endogenous LRRK2 in mouse Swiss 3T3 cells.
Kinase Assay
PFV integration assay: For quantitative strand transfer assays, donor DNA substrate is formed by annealing HPLC grade oligonucleotides 5′-GACTCACTATAGGGCACGCGTCAAAATTCCATGACA and 5′-ATTGTCATG GAATTTTGACGCGTGCCCTATAGTGAGTC. Reactions (40 μL) contains 0.75 μM PFV IN, 0.75 μM donor DNA, 4 nM (300 ng) supercoiled pGEM9-Zf(?) target DNA, 125 mM NaCl, 5 mM MgSO4, 4 μM ZnCl2, 10 mM DTT, 0.8% (vol/vol) DMSO, and 25 mM BisTris propane–HCl, pH 7.45. Raltegravir is added at indicated concentrations. Reactions are initiated by addition of 2 μL PFV IN diluted in 150 mM NaCl, 2 mM DTT, and 10 mM Tris-HCl, pH 7.4, and stopped after 1 hour at 37 °C by addition of 25 mM EDTA and 0.5% (wt/vol) SDS. Reaction products, deproteinized by digestion with 20 μg proteinase K for 30 minutes at 37 °C followed by ethanol precipitation, are separated in 1.5% agarose gels and visualized by staining with ethidium bromide. Integration products are quantified by quantitative real-time PCR, using Platinum SYBR Green qPCR SuperMix and three primers: 5′-CTACTTACTCTAGCTTCCCGGCAAC, 5′-TTCGCCAGTTAATAGTTTGCGCAAC, and 5′-GACTCACTATAGGGCACGCGT. PCR reactions (20 μL) contained 0.5 μM of each primer and 1 μL diluted integration reaction product. Following a 5-min denaturation step at 95 °C, 35 cycles are carried out in a CFX96 PCR instrument, using 10 seconds denaturation at 95 °C, 30 seconds annealing at 56 °C and 1 minutes extension at 68 °C. Standard curves are generated using serial dilutions of WT PFV IN reaction in the absence of INSTI.
Chemical Properties
Molecular Weight399.42
FormulaC24H18FN3O2
Cas No.1285515-21-0
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 4.5 mg/mL (11.27 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5036 mL12.5182 mL25.0363 mL125.1815 mL
5 mM0.5007 mL2.5036 mL5.0073 mL25.0363 mL
10 mM0.2504 mL1.2518 mL2.5036 mL12.5182 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GSK2578215A | purchase GSK2578215A | GSK2578215A cost | order GSK2578215A | GSK2578215A chemical structure | GSK2578215A in vivo | GSK2578215A in vitro | GSK2578215A formula | GSK2578215A molecular weight